Medical DevicesCompanies & operators

Sri Trang Gloves

Sri Trang Gloves (SET: STGT) is a world top-5 medical, examination glove manufacturer by capacity. FY2024 consolidated revenue approximately THB 27B. Vertically integrated — parent Sri Trang Agro-Industry (STA) supplies natural, synthetic rubber feedstock, giving STGT structural cost advantage vs Malaysian peers (Top Glove, Hartalega, Kossan). ~80% export-oriented across US, EU, Japan, ASEAN. Post-COVID glove oversupply cycle 2022-2024 compressed margins materially; recovery pace is the near-term variable.

Snapshot

Headline numbers a buyer checks first.

FY2024 revenue

~THB 27B

FY2024

Rank

World top-5 medical/exam glove

FY2024

Ticker

SET: STGT

Listed 2020

Integration

Sri Trang Agro-Industry rubber parent

Vertical

What this company actually does

STGT manufactures nitrile, latex medical, examination gloves at massive scale in southern Thailand. Parent Sri Trang Agro-Industry (STA) supplies rubber feedstock; STGT operates gloving plants, export logistics. Customer mix: hospital, clinic, distributor, industrial globally with US, EU as largest markets. COVID demand-spike 2020-2021 drove record margins; post-COVID oversupply cycle 2022-2024 compressed industry margins across Thai, Malaysian cluster.[]

Strategic position: STGT is Thailand's anchor medical-consumables manufacturer, structural cost-advantage player via rubber-vertical integration. Competitive set: Top Glove, Hartalega, Kossan (Malaysia). Post-COVID cycle recovery, synthetic-nitrile vs natural-latex feedstock mix, ESG, labour-compliance reputation management are the binding variables.[, ]

Sri Trang Gloves FY2024 56-1Sri Trang Agro-Industry parent disclosures
Data as of: FY2024

Operations footprint

Manufacturing capacity

World top-5 glove producer

Multiple production lines in Hat Yai, Songkhla and satellite facilities. Annual capacity approximately 40-50 billion gloves (nitrile and latex combined). Post-COVID expansion brought additional lines online before the oversupply correction compressed utilisation to approximately 60-70% through 2022-2024.

Vertical integration

Sri Trang Agro-Industry rubber supply

Parent Sri Trang Agro-Industry (STA, SET:STA) is one of Thailand's largest natural-rubber processors, supplying concentrated latex and RSS grades directly to STGT plants. Cost advantage vs Malaysian peers (Top Glove, Hartalega, Kossan) who procure rubber at spot is approximately USD 0.10-0.20 per glove.

Product mix

Nitrile 70%, latex 30%

Nitrile (synthetic, acrylonitrile-butadiene) accounts for approximately 70% of volume — driven by hospital and industrial demand for latex-allergy-free protection. Natural latex gloves retain share in examination and dental segments. Nitrile feedstock (acrylonitrile) is petrochemical-derived; prices track oil and chemical cycles.

Export markets

~80% export — US, EU, Japan, ASEAN

US is the largest single market (healthcare procurement, distributor networks); EU second (regulated healthcare, PPE mandate). Japan and ASEAN supplement. Export is sold via distributors, group purchasing organisations (GPOs), and direct hospital procurement frameworks. Thai origin benefits from no US punitive tariff vs Malaysian peers.

Medical glove peer comparison

FY2024 estimates. Sources: company filings.

Sri Trang Gloves

Ticker

SET:STGT

FY2024 revenue

~ $782.6M

Annual capacity (bn pcs)

~40-50B

Rubber integration

Yes (STA parent)

Top Glove

Ticker

MYX:7113

FY2024 revenue

~MYR 3-4B

Annual capacity (bn pcs)

~100B

Rubber integration

Partial

Hartalega

Ticker

MYX:5168

FY2024 revenue

~MYR 2-3B

Annual capacity (bn pcs)

~45B

Rubber integration

None

Kossan Rubber

Ticker

MYX:7153

FY2024 revenue

~MYR 2B

Annual capacity (bn pcs)

~30B

Rubber integration

None

Key drivers 2025-2026

Oversupply recovery

Industry utilisation normalisation

Post-COVID glove oversupply built up 2021-2023 as pandemic-era expansion collided with demand normalisation. Industry utilisation needs to recover above 75-80% globally before pricing power returns. Thai baht appreciation vs US dollar is an additional headwind for USD-export revenues converted back to THB.

US tariff advantage

Malaysian competitor tariff exposure

US tariffs on Malaysian glove imports (triggered by forced-labour investigations at Top Glove and Supermax) gave STGT a relative cost advantage in US hospital procurement. Continued enforcement or extension of these tariffs would structurally favour Thai and other non-Malaysian producers in the US market.

ESG compliance

Labour-standard certification

Post-Supermax, global hospital GPOs tightened social-compliance auditing for glove suppliers. STGT's compliance track record and SA8000 or equivalent certifications are a competitive differentiator in retaining tier-1 US and EU hospital contracts. Any adverse audit finding would risk contract loss.

Watchpoints

Glove oversupply cycle recovery

Industry utilisation, pricing normalisation pace.

Synthetic-nitrile vs natural-latex mix

Feedstock cost, customer-preference shift.

STA parent rubber-feedstock cost

Vertical-integration advantage pass-through.

ESG, labour compliance

Migrant-worker, environmental audits affect customer retention.

Related Market profiles

Peers, parents, partners, agencies, and other Medical Devices actors.

Sources + data provenance

Every filing, filing-adjacent register, or trusted industry source cited in this profile.

Sri Trang Gloves PCL (SET: STGT) FY2024 Form 56-1 One Report

Publisher

Sri Trang Gloves (Thailand) PCL

Grade

Primary

As of

2025-03-31

Auto-generated from the company source registry.
Primary filings are the first choice. Trusted industry research (Fitch, S&P, Moody's, Opensignal, GSMA, Omdia, JLL, Knight Frank, CBRE, Colliers, STR, etc.) is used for triangulation per SOP — never as the sole anchor.

Reports featuring this profile

Related Market profiles

Key statistics for this sector

Sri Trang Gloves - Market Atlas · Insight